Related Technologies - Columbia Technology Ventures

Search text

About 24 results

(0.14 seconds)

Deep learning model for cardiac right ventricular volume quantification

CU23237

However, the gold standard for right ventricular quantification, cardiovascular magnetic resonance imaging (CMR), is not widely available, whereas widely used imaging techniques such as two-dimensional transthoracic echocardiography (2DE) are typically inaccurate due to the complex geometry of the right ventricle.

This technology is an attention-based deep learning for cardiac right ventricular volume quantification using 2D echocardiography.

To diagnose cardiac diseases and follow up response to treatment, doctors often need accurate measurements of the right ventricle, a core structure of the heart.

5Deep learning Echocardiography Machine vision

Archontis Giannakidis Polydoros Kampaktsis

Joan Martinez

Cardiology

Columbia University Medical Center (CUMC)

2024-01-19

Targeted pharmacological agents for the prevention of multiple organ failure in hemorrhagic shock patients

CU23263

The Technology: Pharmacological agent-based therapy for multiple organ failure prevention.

This technology is a pharmacological intervention targeting localized inflammatory responses in trauma and hemorrhagic shock to prevent multiple organ failure.

The current strategies for managing trauma and hemorrhagic shock (T/HS) primarily aim at symptom management and patient stabilization but fall short in preventing the progression to multiple organ failure (MOF) in survivors.

16Adenosine Adenosine receptor Agent-based model

George Hasko Taha Kelestemur

Kristin Neuman

Anesthesiology

Columbia University Medical Center (CUMC)

2024-04-25

Treatment of systolic heart failure without increased heart rate (tachycardia)

CU19251

This technology is a small molecule protein therapeutic for systolic heart failure, which improves contractility without an unwanted rise in a patient’s heart rate.

Advanced systolic heart failure is a serious condition, often treated with inotropes.

The Technology: Selective small-molecule therapeutic for systolic heart failure.

13Biopharmaceutical Blood pressure Cardiac arrest

4Alexander Kushnir Arianne Papa Guoxia Liu

Joan Martinez

Cardiology Medicine Physiology and Cellular Biophysics

Columbia University Medical Center (CUMC)

2023-11-03

Pharmacological treatment for right ventricular failure